Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 GENFIT S A/ADRDBV TECHNOLOGIE/SCellectisOsiris TherapeuticsMesoblast
SymbolNASDAQ:GNFTNASDAQ:DBVTNASDAQ:CLLSN/ANASDAQ:MESO
Price Information
Current Price$17.55$9.46$11.56N/A$6.82
52 Week RangeBuyHoldBuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyN/ABuy
Consensus Price Target$52.6175$15.2813$34.60N/A$12.40
% Upside from Price Target199.81% upside61.54% upside199.31% upsideN/A81.82% upside
Trade Information
Market Cap$680.24 million$580.84 million$503.46 million$655.69 million$683.65 million
BetaN/A1.811.76N/A1.77
Average Volume19,938149,67892,051202,29376,092
Sales & Book Value
Annual RevenueN/A$17.17 million$21.43 millionN/A$16.72 million
Price / SalesN/A33.2322.90N/A40.68
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$2.41 per share$10.82 per shareN/A$5.11 per share
Price / BookN/A3.931.07N/A1.33
Profitability
Net IncomeN/A$-196,140,000.00$-78,690,000.00N/A$-89,800,000.00
EPSN/A($3.39)($1.93)N/A($0.91)
Trailing P/E Ratio0.000.000.000.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-813.06%N/A-536.97%
Return on Equity (ROE)N/AN/A-21.51%N/A-17.66%
Return on Assets (ROA)N/AN/A-18.56%N/A-13.28%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%0.11%N/A0.14%
Current RatioN/A3.34%8.47%N/A1.41%
Quick RatioN/A3.30%8.46%N/A1.41%
Ownership Information
Institutional Ownership Percentage10.19%52.69%32.30%0.28%2.76%
Insider Ownership PercentageN/A15.31%16.41%43.40%18.80%
Miscellaneous
Employees148244161N/A81
Shares Outstanding37.83 million60.32 million42.45 million34.53 million99.73 million
Next Earnings DateN/AN/A11/12/2019 (Estimated)N/A11/21/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 GENFIT S A/ADRDBV TECHNOLOGIE/SCellectisOsiris TherapeuticsMesoblast

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel